Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Predictive Oncology Inc. - Common Stock
(NQ:
POAI
)
5.950
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Predictive Oncology Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
February 19, 2025
From
Predictive Oncology Inc.
Via
GlobeNewswire
What's Going On With Predictive Oncology Shares Tuesday?
↗
February 18, 2025
Predictive Oncology stock is trading higher on Tuesday after the company reported positive results from utilizing artificial intelligence for drug repurposing.
Via
Benzinga
Topics
Artificial Intelligence
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing
February 18, 2025
From
Predictive Oncology Inc.
Via
GlobeNewswire
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
February 10, 2025
From
Predictive Oncology Inc.
Via
GlobeNewswire
(POAI) - Analyzing Predictive Oncology's Short Interest
↗
January 23, 2025
Via
Benzinga
POAI Stock Earnings: Predictive Oncology Reported Results for Q2 2024
↗
August 13, 2024
Predictive Oncology just reported results for the second quarter of 2024.
Via
InvestorPlace
Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
January 16, 2025
From
Predictive Oncology Inc.
Via
GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, NARI, ML, POAI on Behalf of Shareholders
January 11, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
January 07, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates RHE, FUBO, POAI on Behalf of Shareholders
January 07, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
Renovaro Issues Shareholder Letter and Provides Corporate Update
January 07, 2025
From
Renovaro Inc
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Predictive Oncology Inc. (Nasdaq - POAI), SunLink Health Systems, Inc. (NYSE American - SSY), Universal Stainless & Alloy Products, Inc. (Nasdaq - USAP), Patterson
January 06, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders
January 06, 2025
From
Halper Sadeh LLC
Via
Business Wire
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
January 06, 2025
From
Renovaro Inc
Via
GlobeNewswire
Predictive Oncology Announces Agreement to be Acquired by Renovaro
January 06, 2025
From
Predictive Oncology Inc.
Via
GlobeNewswire
Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives
December 03, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
This SolarEdge Technologies Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
↗
November 15, 2024
Via
Benzinga
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update
November 13, 2024
Company initiates process to explore a broad range of strategic alternatives to maximize shareholder value
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
September 05, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 05, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Reports on Study Confirming Long-Term Stability, Viability of Proprietary Tumor Specimen Biobank
August 27, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
August 27, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Q2 2024 Financial Results, Provides Business Update
August 14, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024
Company to host investor call and webcast today, August 14th, at 8:30am EDT
From
Predictive Oncology Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Expansion of Live-Cell Tumor Platform Applications
August 13, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
August 13, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q2 2024 Financial Results, Conference Call
August 07, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
August 07, 2024
Management to host conference call and webcast at 8:30am ET
From
Predictive Oncology Inc.
Via
GlobeNewswire
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
July 26, 2024
Via
Benzinga
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters into $1.2M Agreement for Exercise of Warrants
July 26, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit